NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Personal Services · USD

Medifast, Inc. (MED) Stock Analysis

Medifast, Inc. (MED) is a Personal Services stock listed on NYSE and quoted in US Dollar.

MED

$12.63

+$0.09 (+0.72%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MED with… →

MED Key Statistics

As of Sep 4, 2026
Trading
Open
$12.53
Previous Close
$12.54
Day's Range
12.37–12.66
52-Week Range
9.22–14.67
Volume
54.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.73
Valuation
Market Cap
$141.21M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.97
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.45
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.33
Financials (FY)
Revenue (FY)
$385.79M−35.96%
Net Income (FY)
−$18.67M−992.97%
Profit marginThe share of revenue left as profit after all costs and taxes.
−8.08%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
11.18M
1-Year Return
−8.81%
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
209.88K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MED Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+18.26%
2025−39.39%
2024−73.79%
2023−38.34%
2022−42.31%
2021+9.36%
2020+86.18%
2019−9.73%
2018+82.11%
2017+72.33%
2016 (partial year)+19.75%

As of September 4, 2026.

MED Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$385.79M−$18.67M−4.8%
2024$602.46M$2.09M0.3%
2023$1.07B$99.42M9.3%
2022$1.60B$143.57M9.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$385.79M$275.19M−$14.21M−$18.67M−4.8%
2024$602.46M$444.62M$2.88M$2.09M0.3%
2023$1.07B$775.85M$126.40M$99.42M9.3%
2022$1.60B$1.14B$184.81M$143.57M9.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MED Valuation vs Personal Services Median

Median of 16 stocks
MetricMEDPersonal Services medianvs median
P/S ratio0.451.0055% below
Profit margin−8.08%2.71%10.8 pts below

Medians across 16 Personal Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Medifast, Inc. (MED) carries a market capitalisation of $141.21M. The company sits in the Consumer Cyclical sector, in the Personal Services industry. Headcount on file is 380.

The most recent close on file for MED is $12.63, dated September 4, 2026. That is +$0.09 (+0.72%) against the previous close. Over the past 52 weeks the price has ranged from $9.22 to $14.67. The latest close sits 36.98% above that 52-week low.

Financial Health

In fiscal 2025, Medifast, Inc. reported revenue of $385.79M. Against the prior fiscal year total of $602.46M, that is a change of −35.96%. The same year closed with a net loss of $18.67M. The reported profit margin is −8.08%. That is 10.8 percentage points below the Personal Services median of 2.71%. Trailing earnings per share are −2.33.

Across the 4 fiscal years on file, revenue moves from $1.60B in 2022 to $385.79M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.97. Measured against sales, the shares trade at 0.45 times revenue. On price-to-sales that is 55.22% below the Personal Services median of 1. The medians here are taken across 16 Personal Services companies that report the metric.

Over the trailing twelve months the price has returned −8.81%. Across 10 years the annualized return works out at −7.89%. Beta against the wider market is reported at 0.73. Annualized volatility over the trailing 10 years is 49.2%.

Growth & Income

No dividend is on file for MED.

So far in 2026 the price is +18.26%. The strongest complete calendar year on file is 2020 at +86.18%; the weakest is 2024 at −73.79%. Of the 9 complete calendar years on file, 4 finished higher.

Peer Comparison

Medifast, Inc. (MED) operates in the Personal Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Medifast, Inc. MED $141.21M —
Rollins, Inc. ROL $17.25B 32.6
Service Corporation International SCI $11.20B 21.6
Andersen Group Inc. ANDG $6.35B 125.0

The Personal Services industry average P/E ratio is 21.6x. Medifast, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Personal Services Stocks

ROL

Rollins, Inc.

$17.25B

 SCI

Service Corporation International

$11.20B

 ANDG

Andersen Group Inc.

$6.35B

 HRB

H&R Block, Inc.

$6.05B

 FTDR

Frontdoor, Inc.

$5.69B

 BFAM

Bright Horizons Family Solutions Inc.

$3.42B
View all Personal Services stocks →

Popular Consumer Cyclical Stocks

AMZN

Amazon.com, Inc.

$2.79T

 TSLA

Tesla, Inc.

$1.40T

 HD

The Home Depot, Inc.

$320.31B

 BABA

Alibaba Group Holding Limited

$281.47B

 TM

Toyota Motor Corporation

$233.41B
View all Consumer Cyclical stocks →

About Medifast, Inc.

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Visit website →